SPI Infoamtion

Table of Contents

Chapter I: Executive Overview of the Space

• Regenerative Medicine is a Global Field
• Regenerative Medicine, Tissue Engineering, and Cellular Therapy
• The Waves of Cellular Therapy
• Worldwide Total Quantitative Market Oppourtunity and Growth in the Stem Cells Space
• Stem Cells Market Forecast by Technology/Product Type
• Stem Cells Market Forecast by Global Region
• US Patient Populations Amenable to Cellular Therpaies
• Cellular Therapy Quantitative Market Opportunity
• Business Models in the Cellular Therapy Space

Chapter II: Stem Cell Worldwide Market Survey Data

• Characterization of Respondent Pool
• Primary Research Applications of Stem Cells
• ESC Utilization
• IPSC Utilization
• MSC Utilization
• HSC Utilization
• NSC Utilization
• Quantitative Market Penetrancce of Vendors Offering Products for the Stem Cells Marketplace
• Drug Discovery, Toxicity Screening using Stem Cells: Market Characteristics
• Penetrance of Different Cell Types for Cellular Therapy Applications
• Differentiationi of iPSCs, hESCs, MSCs, HSCs, NSCs into Various Lineages
• Markers for Characterizing hESCs, iPSCs, MSCs, HSCs, NSCs
• Breakout of Therapeutics Areas in Cellular Therapy: Cardiovascular Diseases, CNS Diseases
• Cellular Therapeutics Timeline: Cardiovascular Diseases, CNS Diseases
• Cellular Therapeutic Delivery Routes: Cardiovascular Diseases, CNS Diseases
• Cell Types for Cellular Therapy of Cardiovascular Disease, CNS Diseases
• Cell Types for Cellular Therapy of Cardiovascular Disease, CNS Disease
• Proposed Mechanism of Action of Cellular Therapeutics

Chapter III: Cord Blood Market Landscape

• Chronology of Cord Blood Transplantation
• Cord Blood Banking: Market Characteristics
• Cord Blood Units Stored in Public Cord Blood Banks: Updated as of December 2009
• Various Public Cord Blood Registries Worldwide: Breakout of Stored Cord Blood Units
• BMSC Donors Worldwide
• Cord Blood Banking: Market Metrics, Market Trends, Market Drivers[
• Engrafting Efficiency with Cord Blood
• Cord Blood Transplants versus None Marrow Transplants
• Private Cord Blood Banks
• Quantitative Transplantation Trends for Adult Recipients versus Pediatric Recipients

Appendix I. Research Methodology

Appendix II. Current Use and Outcome of Hematopoietic Stem Cell Transplantation

• Quantitative Characteristics: Autologous versus Allogeneic Transplantation

Appendix III. Mesenchymal Stem Cells [MSCs] for Cellular Therapy

• Definition and Properties
• MSC Phenotype
• Mechanism of MSC-mediated Tissue Repair
• Fetal versus Adult MSCs